143 related articles for article (PubMed ID: 33833588)
21. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
[TBL] [Abstract][Full Text] [Related]
22. Reliability and validity of the Japanese version of the Mental Health Self-management Questionnaire among people with mental illness living in the community.
Morita Y; Miyamoto Y; Takano A; Kawakami N; Coulombe S
BMC Psychol; 2019 May; 7(1):30. PubMed ID: 31118086
[TBL] [Abstract][Full Text] [Related]
23. Baduanjin exercise improved premenstrual syndrome symptoms in Macau women.
Zhang H; Zhu M; Song Y; Kong M
J Tradit Chin Med; 2014 Aug; 34(4):460-4. PubMed ID: 25185365
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Premenstrual Breakthrough of Depression With Adjunctive Oral Contraceptive Pills Compared With Placebo.
Peters W; Freeman MP; Kim S; Cohen LS; Joffe H
J Clin Psychopharmacol; 2017 Oct; 37(5):609-614. PubMed ID: 28816924
[TBL] [Abstract][Full Text] [Related]
25. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome.
Borenstein JE; Dean BB; Yonkers KA; Endicott J
Obstet Gynecol; 2007 May; 109(5):1068-75. PubMed ID: 17470584
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a natural S-equol supplement in treating premenstrual symptoms and the effect of the gut microbiota: An open-label pilot study.
Takeda T; Chiba Y
Neuropsychopharmacol Rep; 2022 Jun; 42(2):127-134. PubMed ID: 35128842
[TBL] [Abstract][Full Text] [Related]
27. Psychosomatic symptoms questionnaire (PSQ-39): a psychometric study among general population of Iranian adults.
Heidari Z; Feizi A; Rezaei S; Roohafza H; Adibi P
BMC Psychiatry; 2021 May; 21(1):269. PubMed ID: 34034698
[TBL] [Abstract][Full Text] [Related]
28. Development of a Japanese version of the reported and intended behaviour scale: reliability and validity.
Yamaguchi S; Koike S; Watanabe K; Ando S
Psychiatry Clin Neurosci; 2014 Jun; 68(6):448-55. PubMed ID: 24920378
[TBL] [Abstract][Full Text] [Related]
29. Menstrual Cycle Characteristics and Premenstrual Syndrome Prevalence Based on the Daily Record of Severity of Problems in Korean Young Adult Women.
Kim YJ; Park YJ
J Korean Acad Nurs; 2020 Feb; 50(1):147-157. PubMed ID: 32131079
[TBL] [Abstract][Full Text] [Related]
30. The Psychological Inflexibility in Pain Scale (PIPS): Validity and Reliability of the Japanese Version for Chronic Low Back Pain and Knee Pain.
Nagasawa Y; Shibata A; Fukamachi H; Ishii K; Wicksell RK; Oka K
J Pain Res; 2021; 14():325-332. PubMed ID: 33568939
[TBL] [Abstract][Full Text] [Related]
31. Association between Premenstrual Symptoms and Posttraumatic Stress Symptoms by COVID-19: A Cross-Sectional Study with Japanese High School Students.
Takeda T; Kai S; Yoshimi K
Tohoku J Exp Med; 2021 Sep; 255(1):71-77. PubMed ID: 34588375
[TBL] [Abstract][Full Text] [Related]
32. Psychometric assessment of the Japanese version of the Revised Fibromyalgia Impact Questionnaire: reliability and validity.
Isomura T; Nakamura I; Kawaguchi M; Sato E; Inuzuka K; Osada K; Nishioka K; Hayakawa K
Int J Rheum Dis; 2017 Sep; 20(9):1088-1094. PubMed ID: 25939290
[TBL] [Abstract][Full Text] [Related]
33. Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
Yonkers KA; Kornstein SG; Gueorguieva R; Merry B; Van Steenburgh K; Altemus M
JAMA Psychiatry; 2015 Oct; 72(10):1037-44. PubMed ID: 26351969
[TBL] [Abstract][Full Text] [Related]
34. Construct validity and reliability of the Bilateral Vestibulopathy Questionnaire (BVQ).
van Stiphout L; Rolfes J; Waardenburg S; Kimman M; Guinand N; Pérez Fornos A; Van Rompaey V; van de Berg R
Front Neurol; 2023; 14():1221037. PubMed ID: 38020641
[TBL] [Abstract][Full Text] [Related]
35. How to measure the impact of premenstrual symptoms? Development and validation of the German PMS-Impact Questionnaire.
Kues JN; Janda C; Kleinstäuber M; Weise C
Women Health; 2016 Oct; 56(7):807-26. PubMed ID: 26624615
[TBL] [Abstract][Full Text] [Related]
36. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea.
Witjes H; Creinin MD; Sundström-Poromaa I; Martin Nguyen A; Korver T
Eur J Contracept Reprod Health Care; 2015; 20(4):296-307. PubMed ID: 25712537
[TBL] [Abstract][Full Text] [Related]
38. [The validity and reliability of simplified Chinese version of the pediatric sleep questionnaire for screening children with obstructive sleep apnea syndrome in Beijing].
Li XD; Tai J; Xu ZF; Peng XX; Feng GS; Zhang YM; Zhang J; Guo YL; Wu YX; Shi J; Wang SC; Ni X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Nov; 51(11):812-818. PubMed ID: 27938606
[No Abstract] [Full Text] [Related]
39. Acupuncture and acupressure for premenstrual syndrome.
Armour M; Ee CC; Hao J; Wilson TM; Yao SS; Smith CA
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005290. PubMed ID: 30105749
[TBL] [Abstract][Full Text] [Related]
40. [Premenstrual syndrome and premenstrual dysphoric disorder].
Kovács Z; Hegyi G; Szőke H
Orv Hetil; 2022 Jun; 163(26):1023-1031. PubMed ID: 35895486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]